About this podcast
Most cannabis companies won't survive the next three years. The ones that do will have better capital discipline, sharper regulatory reads, and operational frameworks built for compression, not growth. The Dime is where cannabis operators, executives, and investors hear directly from the CEOs and founders making those decisions right now: MSO strategy, state-by-state market dynamics, cultivation and extraction economics, brand positioning, and the financing structures keeping companies alive. Bryan Fields hosts weekly conversations built for operators, not observers.
Episodes
The newest 20 of 309 episodes
- Europe's 51st State, EU GMP, and Building Before the Market Arrives ft. Michael Sassano · 56 min · Episode 311The expensive decision rarely looks intelligent before the market needs it. Operators can build for the regulations in front of them, or for the direction regulators are already…
- How AYRLOOM Built Its Advantage in New York Cannabis ft. Eddie Brennan · 44 min · Episode 310A 115-year farm discovered that preserving the legacy meant letting a new crop compete with it. Ayrloom reached Beak & Skiff's revenue scale in three years, then forced the…
- Who Benefits From Federal Cannabis Limbo? ft. Jay Rosenthal · 53 min · Episode 309Federal cannabis reform is supposed to open the same door for everyone. The current market says otherwise. The largest operators do not share one political agenda, and some of…
- What Makes Consumers Buy the Same Edible Again? ft. Kim Sanchez Rael · 42 min · Episode 308Fast-acting edibles can command a premium, but labels such as "nano" do not prove the final product works. The larger operating question is whether the formulation improves…
- Europe Is Not a Rescue Plan ft. Jamie Pearson · 48 min · Episode 307Jamie Pearson of New Holland Group joins Bryan Fields on The Dime to discuss European cannabis expansion, EU GMP standards, medical cannabis supply chains, and why operational…
- Paige Figi: The Cannabis Industry Is Cheering A Ban On Medicine · 53 min · Episode 306Much of the licensed cannabis industry is quietly counting the volume it expects to inherit from the federal hemp ban coming this November. \*\* Now December. What they may not…
- Understand This Before You Use AI To Build Software ft. Chris Guthrie · 50 min · Episode 305AI has made software easier than ever to build. That does not mean every internal tool should become the backbone of your business. In this episode, Bryan sits down with Chris…
- Hirsh Jain: Rescheduling Is Already Picking Winners · 1 h 11 min · Episode 304Cannabis rescheduling is not as simple as “Trump rescheduled cannabis.” States are interpreting rescheduling completely differently depending on their license structure. These…
- Germany Is the Engine: What BAT Knows That Cannabis Doesn't ft. James Yamanaka · 42 min · Episode 303Predictable cash flow is the whole game. In cannabis, predictable is the one thing almost nobody has. Organigram CEO James Yamanaka came up over 20 years at British American…
- Why Ohio Cannabis Is Built Different: Inside the Regulator-Operator Alignment That's Actually Working ft. Caroline Henry · 48 min · Episode 302When a regulator asks what the downside is of adding one more testing requirement, what is the downside? Just a little more safe. Just in case. Especially when adding one more…
- Cannabis Was Medicine. Now the Proof Is Catching Up, ft. Joel Stanley and Dr. Marcel Bonn-Miller · 51 min · Episode 301The cannabis industry convinced the world it had a medicine before the science caught up. Now the science is here, and almost no one is paying attention. CBD is not a panacea…
- Joe Lustberg: What Cannabis Lenders See That Operators Miss · 44 min · Episode 300The cash amount in your head and the cash you actually need are not the same number. That gap is where most cannabis businesses break. Joe Lustberg has financed operators across…
- The Hidden Margin Killer for MSOS ft. Braunz Muller · 58 min · Episode 299Cannabis operators aren't short on data. They're drowning in it. The real problem is what happens when that data gets handed to the wrong person, read at the wrong time, or used…
- Ed Rosenthal and Greg Baughman: You're Still Growing Cannabis Wrong · 55 min · Episode 298A customer walks into the dispensary and asks the budtender for a flower recommendation. They end up with a degraded version of the once high-end flower that graced your…
- The Legal Market Was Never Built for Payments, Why Cannabis Still Breaks the Rules ft. Aubrey Amatelli · 41 min · Episode 297The largest payment processor in the world handles cannabis in Canada. In the U.S., they will not touch it. That’s the gap. Aubrey Amatelli left JP Morgan believing that if you…
- Gretchen Gailey: Cannabis Industry Has No Idea How DC Works, Why Rescheduling Is Delayed · 53 min · Episode 296Politics is a dirty business. Sometimes being feared is the influence you need because access is not the problem. Politicians say "we'll take care of this." Gretchen Gailey has a…
- 15 Years of Cannabis Trading . Why I'll Sell Early (Unless This Happens) ft. Dan McDermitt · 40 min · Episode 295Investing in cannabis requires a split personality. Everyone thinks they're early. Dan McDermitt has been trading the sector for 15 years — through the Canadian boom, the Biden…
- Premium vs Scale in Cannabis: Inside Rubicon’s Strategy ft. Margaret Brodie · 51 min · Episode 294Most cannabis companies chased scale. Rubicon chased quality. What does it actually take to build a premium cannabis brand? Trust sits behind what “premium” really means, why…
- Prop 64 Fine Print, Pesticide Drift, The Economics Behind Concentrates ft. Micah Anderson · 54 min · Episode 293When California legalized cannabis, did anyone see 70% of the state opting out. Retail access never recovered. The illicit market stayed durable. And taxes kept compounding…
- JB (Cheech & Chong CEO): Building a National Cannabis Brand Through Trial, Error & Partnership · 45 min · Episode 292Everyone knows the Cheech & Chong name. Almost no one understands the infrastructure behind it. This isn’t a celebrity brand story. It’s a leverage story inside a fragmented…
